{"id":34121,"date":"2026-02-12T15:24:23","date_gmt":"2026-02-12T09:54:23","guid":{"rendered":"https:\/\/www.legalraasta.com\/blog\/?p=34121"},"modified":"2026-04-03T17:10:59","modified_gmt":"2026-04-03T11:40:59","slug":"selling-without-cdsco-approval-penalties","status":"publish","type":"post","link":"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/","title":{"rendered":"Selling Drugs or Medical Devices Without CDSCO Approval: Fines, Legal Risks &amp; Penalties"},"content":{"rendered":"<p style=\"text-align: justify\"><span style=\"font-weight: 400\">The pharmaceutical and medical device regulatory landscape in India has reached a critical turning point in 2026. With the full integration of the <\/span><b>Jan Vishwas Act Pharma Penalties 2026<\/b><span style=\"font-weight: 400\"> and the newly notified <\/span><b>Drugs and Cosmetics (Compounding of Offences) Rules, 2025<\/b><span style=\"font-weight: 400\">, the Central Drugs Standard Control Organisation (CDSCO) has shifted toward a &#8220;trust-based&#8221; yet high-stakes enforcement model. While the government has moved to decriminalise minor technical errors, the <\/span><a href=\"https:\/\/www.legalraasta.com\/blog\/cdsco-medical-device-license-india\/\"><span style=\"font-weight: 400\">CDSCO<\/span><\/a><span style=\"font-weight: 400\"> approval penalties for quality-related negligence\u2014such as the sale of spurious drugs or non-compliance with QR code mandates\u2014have become more aggressive, involving immediate <\/span><b>Pharma Stop Production Orders (SPO) 2026<\/b><span style=\"font-weight: 400\"> and nationwide product seizures.<\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">The regulatory experts at LegalRaasta can help to keep your pharma or medical device venture within the recent 2026 requirements.<\/span><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_73 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#The_Jan_Vishwas_Act_Pharma_Penalties_2026_A_Paradigm_Shift\" title=\"The Jan Vishwas Act Pharma Penalties 2026: A Paradigm Shift\">The Jan Vishwas Act Pharma Penalties 2026: A Paradigm Shift<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#CDSCO_Compounding_of_Offences_Rules_2025_Settlement_Procedures\" title=\"CDSCO Compounding of Offences Rules 2025: Settlement Procedures\">CDSCO Compounding of Offences Rules 2025: Settlement Procedures<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#Drugs_and_Cosmetics_Act_Legal_Risks_2026_Risk_Categories\" title=\"Drugs and Cosmetics Act Legal Risks: 2026 Risk Categories\">Drugs and Cosmetics Act Legal Risks: 2026 Risk Categories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#Pharma_Stop_Production_Order_SPO_2026_Seizure_Guidelines\" title=\"Pharma Stop Production Order (SPO) 2026 &amp; Seizure Guidelines\">Pharma Stop Production Order (SPO) 2026 &amp; Seizure Guidelines<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#Medical_Device_Non-Compliance_Fines_India_2026_Risk_Classification\" title=\"Medical Device Non-Compliance Fines India: 2026 Risk Classification\">Medical Device Non-Compliance Fines India: 2026 Risk Classification<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#QR_Code_Compliance_Fines_Schedule_H2_Digital_Mandates\" title=\"QR Code Compliance Fines Schedule H2 &amp; Digital Mandates\">QR Code Compliance Fines Schedule H2 &amp; Digital Mandates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#Unlicensed_Cosmetic_Import_Penalties_Form_42_Violations\" title=\"Unlicensed Cosmetic Import Penalties &amp; Form 42 Violations\">Unlicensed Cosmetic Import Penalties &amp; Form 42 Violations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#Comprehensive_Penalty_Schedule_2026\" title=\"Comprehensive Penalty Schedule 2026\">Comprehensive Penalty Schedule 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#Managing_CDSCO_Risk-Based_Inspection_Penalties\" title=\"Managing CDSCO Risk-Based Inspection Penalties\">Managing CDSCO Risk-Based Inspection Penalties<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#FAQs\" title=\"FAQs\">FAQs<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2 style=\"text-align: justify\"><span class=\"ez-toc-section\" id=\"The_Jan_Vishwas_Act_Pharma_Penalties_2026_A_Paradigm_Shift\"><\/span><b>The Jan Vishwas Act Pharma Penalties 2026: A Paradigm Shift<\/b><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">The <\/span><b>Jan Vishwas Act Pharma Penalties 2026<\/b><span style=\"font-weight: 400\"> is an enormous piece of legislation that attempts to decriminalize about 280 offences in several central acts. Within the pharmaceutical industry, this implies that incarceration covering minor or venial technical violation instances has yielded to formally constructed monetary CDSCO approval penalties.<\/span><\/p>\n<p style=\"text-align: justify\"><b>Key Highlights of the 2026 Reform:<\/b><\/p>\n<ul style=\"text-align: justify\">\n<li style=\"font-weight: 400\"><b>Administrative Adjudication:<\/b><span style=\"font-weight: 400\"> Many offences are not processed immediately through a criminal court, and instead, the process is direct to the Administrative or what is referred to as the Adjudicating Officer, where fines can be imposed.<\/span><\/li>\n<li style=\"font-weight: 400\"><b>Automatic Inflation Adjustment:<\/b><span style=\"font-weight: 400\"> Any monetary penalties would increase by 10% regularly under the new rules every three years, beginning in 2026, which serves as a baseline.<\/span><\/li>\n<li style=\"font-weight: 400\"><b>First-Time Offender Advisory:<\/b><span style=\"font-weight: 400\"> For 76 specified minor offences, the CDSCO can now issue a formal warning or advisory for first-time contraventions instead of an immediate fine.<\/span><\/li>\n<\/ul>\n<h3 style=\"text-align: justify\"><span class=\"ez-toc-section\" id=\"CDSCO_Compounding_of_Offences_Rules_2025_Settlement_Procedures\"><\/span><b>CDSCO Compounding of Offences Rules 2025: Settlement Procedures<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">The <\/span><b>CDSCO Compounding of Offences Rules 2025<\/b><span style=\"font-weight: 400\"> provide a statutory &#8220;exit route&#8221; for manufacturers and importers who have committed non-serious violations. Compounding essentially allows the accused to pay a fine in lieu of prosecution.<\/span><\/p>\n<p style=\"text-align: justify\"><b>Eligibility and Settlement Framework<\/b><\/p>\n<table style=\"width: 98.7382%\">\n<tbody>\n<tr>\n<td style=\"width: 29.5359%\">\n<p><b>Aspect<\/b><\/p>\n<\/td>\n<td style=\"width: 84.0862%\">\n<p><b>Regulation \/ Detail<\/b><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 29.5359%\">\n<p><b>Primary Authority<\/b><\/p>\n<\/td>\n<td style=\"width: 84.0862%\">\n<p><b>Compounding Authority SOPs India<\/b><span style=\"font-weight: 400\"> (ADGHS or State Drug Controller)<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 29.5359%\">\n<p><b>Applicability<\/b><\/p>\n<\/td>\n<td style=\"width: 84.0862%\">\n<p><span style=\"font-weight: 400\">Offences under Section 32B of the Drugs and Cosmetics Act<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 29.5359%\">\n<p><b>Exclusions<\/b><\/p>\n<\/td>\n<td style=\"width: 84.0862%\">\n<p><span style=\"font-weight: 400\">Offences punishable with &#8220;Imprisonment only&#8221; or &#8220;Imprisonment + Fine.&#8221;<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 29.5359%\">\n<p><b>Immunity Status<\/b><\/p>\n<\/td>\n<td style=\"width: 84.0862%\">\n<p><span style=\"font-weight: 400\">Full immunity granted upon <\/span><b>Minor Contravention Settlement, CDSCO<\/b><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"width: 29.5359%\">\n<p><b>Payment Deadline<\/b><\/p>\n<\/td>\n<td style=\"width: 84.0862%\">\n<p><span style=\"font-weight: 400\">Must be remitted within <\/span><b>30 days<\/b><span style=\"font-weight: 400\"> of the compounding order<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3 style=\"text-align: justify\"><span class=\"ez-toc-section\" id=\"Drugs_and_Cosmetics_Act_Legal_Risks_2026_Risk_Categories\"><\/span><b>Drugs and Cosmetics Act Legal Risks: 2026 Risk Categories<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">The CDSCO classifies the <\/span><a href=\"https:\/\/en.wikipedia.org\/wiki\/Drugs_and_Cosmetics_Act,_1940\"><span style=\"font-weight: 400\">Drugs and Cosmetics Act<\/span><\/a><b> Legal Risks<\/b><span style=\"font-weight: 400\"> at three levels according to the effect on the health of citizens. The 2026 enforcement regime uses <\/span><b>CDSCO Risk-Based Inspection Penalties<\/b><span style=\"font-weight: 400\"> to target manufacturers who consistently fail to meet &#8220;Good Manufacturing Practices&#8221; (GMP).<\/span><b><\/b><\/p>\n<ul style=\"text-align: justify\">\n<li><b>Tier 1: Minor\/Technical Contraventions<\/b><\/li>\n<\/ul>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">These include errors in record-keeping, minor labelling mistakes (excluding QR codes), or failure to notify changes in administrative details. These are generally compoundable.<\/span><b><\/b><\/p>\n<ul style=\"text-align: justify\">\n<li><b>Tier 2: Major\/Quality Contraventions (Misbranded &amp; Adulterated)<\/b><\/li>\n<\/ul>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">Violations involving <\/span><b>Misbranded Drug Legal Consequences 2026<\/b><span style=\"font-weight: 400\"> fall here. If a label fails to disclose necessary ingredients or claims false therapeutic benefits, the CDSCO approval penalties are strictly monetary but significantly higher.<\/span><b><\/b><\/p>\n<ul style=\"text-align: justify\">\n<li><b>Tier 3: Critical\/Criminal Contraventions (Spurious Drugs)<\/b><\/li>\n<\/ul>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">The <\/span><b>Spurious Drug Sale Fines 2026<\/b><span style=\"font-weight: 400\"> are still the most extreme. Selling drugs that are imitation products or substituted by other ingredients carries mandatory imprisonment and fines that can extend to the total value of the seized goods.<\/span><\/p>\n<h3 style=\"text-align: justify\"><span class=\"ez-toc-section\" id=\"Pharma_Stop_Production_Order_SPO_2026_Seizure_Guidelines\"><\/span><b>Pharma Stop Production Order (SPO) 2026 &amp; Seizure Guidelines<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">The CDSCO has updated its enforcement manual to include the <\/span><b>CDSCO Product Seizure Guidelines<\/b><span style=\"font-weight: 400\">, which are triggered immediately after a failed risk-based inspection.<\/span><\/p>\n<p style=\"text-align: justify\"><b>Enforcement Actions and Timelines<\/b><\/p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><b>Enforcement Action<\/b><\/p>\n<\/td>\n<td>\n<p><b>Triggering Event<\/b><\/p>\n<\/td>\n<td>\n<p><b>Legal Consequence<\/b><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><b>Stop Production Order (SPO)<\/b><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Failure of critical GMP\/Schedule M standards<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Immediate cessation of manufacturing<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><b>Product Seizure<\/b><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Detection of Spurious or NSQ drugs<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Detainment of raw materials and finished stock<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><b>License Suspension<\/b><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Repeated <\/span><b>Form 42 Registration Violations<\/b><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Temporary ban on trade\/manufacturing (1-6 months)<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><b>Blacklisting<\/b><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Fraudulent data submission in the SUGAM portal<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Permanent bar from participating in government tenders<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3 style=\"text-align: justify\"><span class=\"ez-toc-section\" id=\"Medical_Device_Non-Compliance_Fines_India_2026_Risk_Classification\"><\/span><b>Medical Device Non-Compliance Fines India: 2026 Risk Classification<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">The CDSCO approval penalties on non-compliance with <\/span><a href=\"https:\/\/www.legalraasta.com\/blog\/cdsco-medical-device-license-india\/\"><span style=\"font-weight: 400\">medical devices<\/span><\/a><span style=\"font-weight: 400\"> have been tightened with the publication of the <\/span><b>final risk classification lists <\/b><span style=\"font-weight: 400\">associated with Oncology and Radiotherapy equipment in January 2026. <\/span><b>Medical Device Non-Compliance Fines in India<\/b><span style=\"font-weight: 400\"> are now strictly mapped to the device&#8217;s class (A, B, C, or D).<\/span><\/p>\n<ul style=\"text-align: justify\">\n<li style=\"font-weight: 400\"><b>Class A (Low Risk):<\/b><span style=\"font-weight: 400\"> Focuses on &#8220;Improvement Notices.&#8221; Failure by the manufacturer to correct the mistake within 30 days attracts a fine of Rs 1 Lakh.<\/span><\/li>\n<li style=\"font-weight: 400\"><b>Class D (High Risk):<\/b><span style=\"font-weight: 400\"> Any non-conformity in the production of implants or life-critical equipment prompts an automatic <\/span><b>Pharma Stop Production Order (SPO) 2026<\/b><span style=\"font-weight: 400\"> and will be followed by possible criminal charges under the 2026 norms.<\/span><\/li>\n<\/ul>\n<h3 style=\"text-align: justify\"><span class=\"ez-toc-section\" id=\"QR_Code_Compliance_Fines_Schedule_H2_Digital_Mandates\"><\/span><b>QR Code Compliance Fines Schedule H2 &amp; Digital Mandates<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">The 2026 digital-first compliance initiative has made QR codes on primary packaging non-negotiable for all Schedule H2 drugs.<\/span><\/p>\n<p style=\"text-align: justify\"><b>The CDSCO Approval Penalties for Digital Non-Compliance:<\/b><\/p>\n<ul style=\"text-align: justify\">\n<li style=\"font-weight: 400\"><b>QR Code Compliance Fines Schedule H2:<\/b><span style=\"font-weight: 400\"> Batches found without a functioning, readable QR code containing the unique product ID, batch number, and expiry are classified as <\/span><b>Misbranded<\/b><span style=\"font-weight: 400\">.<\/span><\/li>\n<li style=\"font-weight: 400\"><b>Data Integrity Fines:<\/b><span style=\"font-weight: 400\"> The punishment for the QR code information that has nothing to do with the physical batch records can go up to Rs 2 Lakhs per batch.<\/span><\/li>\n<\/ul>\n<h3 style=\"text-align: justify\"><span class=\"ez-toc-section\" id=\"Unlicensed_Cosmetic_Import_Penalties_Form_42_Violations\"><\/span><b>Unlicensed Cosmetic Import Penalties &amp; Form 42 Violations<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">For importers, the CDSCO approval penalties 2026 have introduced a &#8220;Zero Tolerance&#8221; policy on <\/span><b>Unlicensed Cosmetic Import Penalties<\/b><span style=\"font-weight: 400\">. The importation of cosmetics without a valid Registration Certificate (RC) results in the following:<\/span><\/p>\n<ul style=\"text-align: justify\">\n<li style=\"font-weight: 400\"><b>Product Confiscation:<\/b><span style=\"font-weight: 400\"> Under the <\/span><b>CDSCO Product Seizure Guidelines<\/b><span style=\"font-weight: 400\">, the entire consignment is in custody at the port.<\/span><\/li>\n<li style=\"font-weight: 400\"><b>Form 42 Registration Violations:<\/b><span style=\"font-weight: 400\"> Fraudulent use of Form 42 (application form) or providing false manufacturing site information leads to a permanent block of the importer&#8217;s IEC code on the ICEGATE portal.<\/span><\/li>\n<\/ul>\n<h3 style=\"text-align: justify\"><span class=\"ez-toc-section\" id=\"Comprehensive_Penalty_Schedule_2026\"><\/span><b>Comprehensive Penalty Schedule 2026<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">The following table outlines the consolidated fines as per the <\/span><b>Jan Vishwas Act Pharma Penalties 2026<\/b><span style=\"font-weight: 400\"> and <\/span><b>CDSCO Compounding of Offences Rules 2025<\/b><span style=\"font-weight: 400\">.<\/span><\/p>\n<p style=\"text-align: justify\"><b>2026 Penalty &amp; Settlement Schedule<\/b><\/p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><b>Offence Category<\/b><\/p>\n<\/td>\n<td>\n<p><b>Relevant Section \/ Keyword<\/b><\/p>\n<\/td>\n<td>\n<p><b>Penalty Range (INR)<\/b><\/p>\n<\/td>\n<td>\n<p><b>Compoundable?<\/b><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><b>Minor Procedural Lapse<\/b><\/p>\n<\/td>\n<td>\n<p><b>CDSCO Decriminalization of Minor Offences<\/b><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Rs 10,000 &#8211; Rs 50,000<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Yes<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><b>Non-Disclosure of Manufacturer<\/b><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Section 18A \/ 28<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Rs 20,000 &#8211; Rs 1 Lakh<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Yes<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><b>Schedule H2 QR Failure<\/b><\/p>\n<\/td>\n<td>\n<p><b>QR Code Compliance Fines Schedule H2<\/b><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Rs 50,000 &#8211; Rs 2 Lakhs<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Yes<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><b>Misbranded Drug Sale<\/b><\/p>\n<\/td>\n<td>\n<p><b>Misbranded Drug Legal Consequences 2026<\/b><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Rs 5 Lakhs &#8211; Rs 15 Lakhs<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">No<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><b>Spurious Product Sale<\/b><\/p>\n<\/td>\n<td>\n<p><b>Spurious Drug Sale Fines 2026<\/b><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Rs 10 Lakhs + Imprisonment<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">No<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><b>Import without License<\/b><\/p>\n<\/td>\n<td>\n<p><b>Form 42 Registration Violations<\/b><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">Rs 2 Lakhs + Blacklisting<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400\">No<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3 style=\"text-align: justify\"><span class=\"ez-toc-section\" id=\"Managing_CDSCO_Risk-Based_Inspection_Penalties\"><\/span><b>Managing CDSCO Risk-Based Inspection Penalties<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">In 2026, the CDSCO performs Surprise Risk-Based Inspections of the facilities with past records of NSQ (Not of Standard Quality) alerts.<\/span><\/p>\n<p style=\"text-align: justify\"><b>Survival Guide for Inspections:<\/b><\/p>\n<ol style=\"text-align: justify\">\n<li style=\"font-weight: 400\"><b>SOP Alignment:<\/b><span style=\"font-weight: 400\"> Ensure that the manufacturing SOPs you use are consistent with the <\/span><b>Compounding Authority SOPs in India<\/b><span style=\"font-weight: 400\">.<\/span><\/li>\n<li style=\"font-weight: 400\"><b>Self-Audit:<\/b><span style=\"font-weight: 400\"> Perform monthly internal audits that will help you avoid a <\/span><b>Pharma Stop Production Order (SPO) 2026<\/b><span style=\"font-weight: 400\">.<\/span><\/li>\n<li style=\"font-weight: 400\"><b>Traceability:<\/b><span style=\"font-weight: 400\"> To prevent the Data Mismatch penalties, ensure that the SUGAM portal is real-time updated with batch data.<\/span><\/li>\n<\/ol>\n<h3 style=\"text-align: justify\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><b>Conclusion<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">The 2026 regulatory framework will give incentives to transparent, quality-conscious companies and bring bad actors out of the supply chain in a systematic manner. The government has offered the honest mistake a lifeline through the <\/span><b>CDSCO Decriminalization Minor Offences<\/b><span style=\"font-weight: 400\"> initiative. Nevertheless, to those who disregard the <\/span><b>QR Code Compliance Fines Schedule H2<\/b><span style=\"font-weight: 400\"> or voluntarily put patient health at risk, legal ramifications and imposed CDSCO approval penalties are immediate and harsh. This could be a settlement by the <\/span><b>CDSCO Compounding of Offences Rules 2025<\/b><span style=\"font-weight: 400\"> or a battle over a <\/span><b>Pharma Stop Productions Order (SPO) 2026<\/b><span style=\"font-weight: 400\">; you need an expert lawyer.<\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">LegalRaasta can help your business navigate the difficult issues of CDSCO compliance and penalty settlements in the present and secure its future.<\/span><\/p>\n<h3 style=\"text-align: justify\"><span class=\"ez-toc-section\" id=\"FAQs\"><\/span><b>FAQs<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ol style=\"text-align: justify\">\n<li><b> What are the CDSCO Compounding of Offences Rules 2025?<\/b><\/li>\n<\/ol>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">The <\/span><b>CDSCO Compounding of Offences Rules 2025<\/b><span style=\"font-weight: 400\"> are a set of regulations that allow manufacturers and importers to settle specific legal violations under the Drugs and Cosmetics Act by paying a monetary fine instead of going to court.<\/span><\/p>\n<ol style=\"text-align: justify\" start=\"2\">\n<li><b> How does the Jan Vishwas Act Pharma Penalties 2026 impact a first-time offender?<\/b><\/li>\n<\/ol>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">The <\/span><b>Jan Vishwas Act Pharma Penalties 2026<\/b><span style=\"font-weight: 400\"> lays down that first-time offenders with some technical violations can be given a warning or an advisory (instead of a fine) as an option, which is one of the strategies to have a trust-based compliance regime.<\/span><\/p>\n<ol style=\"text-align: justify\" start=\"3\">\n<li><b> Which violations qualify for a Minor Contravention Settlement CDSCO?<\/b><\/li>\n<\/ol>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">A <\/span><b>Minor Contravention Settlement CDSCO<\/b><span style=\"font-weight: 400\"> can be used with regard to procedural shortcomings, including minor labeling mistakes, record-keeping delays, or administrative modifications, none of which affect the quality or safety of the drug.<\/span><\/p>\n<ol style=\"text-align: justify\" start=\"4\">\n<li><b> What is the penalty for failing QR Code Compliance Fines Schedule H2?<\/b><\/li>\n<\/ol>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">Non-compliance with the <\/span><b>QR Code Compliance Fines Schedule H2 <\/b><span style=\"font-weight: 400\">standards in 2026 may result in the declaration of the batch as Mishandled and impose a fine of between Rs 50000 and Rs 2 Lakh on each batch, and a compulsory recall of the product.<\/span><\/p>\n<ol style=\"text-align: justify\" start=\"5\">\n<li><b> Can a Pharma Stop Production Order (SPO) 2026 be challenged?<\/b><\/li>\n<\/ol>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">Yes, a <\/span><b>Pharma Stop Production Order (SPO) 2026<\/b><span style=\"font-weight: 400\"> may be appealed using the Central or State Government, on the condition that the manufacturer can demonstrate that the mentioned deviations found during the risk-based inspection have been corrected.<\/span><\/p>\n<ol style=\"text-align: justify\" start=\"6\">\n<li><b> What are the CDSCO Product Seizure Guidelines for cosmetics?<\/b><\/li>\n<\/ol>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">The <\/span><b>CDSCO Product Seizure Guidelines<\/b><span style=\"font-weight: 400\"> provide that any cosmetic imported in violation of having a valid Form 43 certificate could be subjected to seizure at the port of entry, and the importer might incur <\/span><b>Unlicensed Cosmetic Import Penalties<\/b><span style=\"font-weight: 400\">.<\/span><\/p>\n<ol style=\"text-align: justify\" start=\"7\">\n<li><b> Are Spurious Drug Sale Fines 2026 compoundable?<\/b><\/li>\n<\/ol>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">No. The violations of <\/span><b>Spurious Drug Sale Fines 2026<\/b><span style=\"font-weight: 400\"> refer to the significant risks of unsatisfactory health of the population and to non-compoundability, as it is strictly forbidden, and many offenders have to face imprisonment and various fines.<\/span><\/p>\n<ol style=\"text-align: justify\" start=\"8\">\n<li><b> How are Medical Device Non-Compliance Fines in India determined?<\/b><\/li>\n<\/ol>\n<p style=\"text-align: justify\"><b>Medical Device Non-Compliance Fines in India <\/b><span style=\"font-weight: 400\">in 2026 are established depending on the threat factor of the device (Class A, B, C, or D), with more threatening devices subjected to much more rigorous fines.<\/span><\/p>\n<ol style=\"text-align: justify\" start=\"9\">\n<li><b> What happens during Form 42 Registration Violations?<\/b><\/li>\n<\/ol>\n<p style=\"text-align: justify\"><b>Form 42 Registration Violations<\/b><span style=\"font-weight: 400\"> represent situations when an importer presents falsified information in the process of a cosmetic import license application. This may result in the certificate of Registration being cancelled and blacklisting against the importing company.<\/span><\/p>\n<ol style=\"text-align: justify\" start=\"10\">\n<li><b> Where can I find the Compounding Authority SOPs in India?<\/b><\/li>\n<\/ol>\n<p style=\"text-align: justify\"><span style=\"font-weight: 400\">The <\/span><b>Compounding Authority SOPs India <\/b><span style=\"font-weight: 400\">can be found on the official CDSCO SUGAM portal and describe the stepwise procedure of the filing of a compounding application, including the required forms and timetables.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The pharmaceutical and medical device regulatory landscape in India has reached a critical turning point in 2026. With the full integration of the Jan Vishwas Act Pharma Penalties 2026 and the newly notified Drugs and Cosmetics (Compounding of Offences) Rules, 2025, the Central Drugs Standard Control Organisation (CDSCO) has shifted toward a &#8220;trust-based&#8221; yet high-stakes enforcement [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":34122,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5155,5247,5250],"tags":[],"class_list":["post-34121","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cdsco","category-drug-license","category-medical-device"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Selling Without CDSCO Approval in India? Fines &amp; Legal Risks<\/title>\n<meta name=\"description\" content=\"Selling medical devices without CDSCO approval can lead to heavy fines and legal action in India. Check penalties by product category.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Selling Without CDSCO Approval in India? Fines &amp; Legal Risks\" \/>\n<meta property=\"og:description\" content=\"Selling medical devices without CDSCO approval can lead to heavy fines and legal action in India. Check penalties by product category.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/\" \/>\n<meta property=\"og:site_name\" content=\"LegalRaasta Knowledge portal\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-12T09:54:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-03T11:40:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.legalraasta.com\/blog\/wp-content\/uploads\/2026\/02\/Selling-Drugs-or-Medical-Devices-Without-CDSCO-Approval.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"288\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Author: LegalRaasta\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Author: LegalRaasta\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/selling-without-cdsco-approval-penalties\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/selling-without-cdsco-approval-penalties\\\/\"},\"author\":{\"name\":\"Author: LegalRaasta\",\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/#\\\/schema\\\/person\\\/8fffceba7148ae1120f0bd4bf73b0c62\"},\"headline\":\"Selling Drugs or Medical Devices Without CDSCO Approval: Fines, Legal Risks &amp; Penalties\",\"datePublished\":\"2026-02-12T09:54:23+00:00\",\"dateModified\":\"2026-04-03T11:40:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/selling-without-cdsco-approval-penalties\\\/\"},\"wordCount\":1680,\"image\":{\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/selling-without-cdsco-approval-penalties\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Selling-Drugs-or-Medical-Devices-Without-CDSCO-Approval.png\",\"articleSection\":[\"CDSCO\",\"Drug License\",\"Medical Device\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/selling-without-cdsco-approval-penalties\\\/\",\"url\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/selling-without-cdsco-approval-penalties\\\/\",\"name\":\"Selling Without CDSCO Approval in India? Fines & Legal Risks\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/selling-without-cdsco-approval-penalties\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/selling-without-cdsco-approval-penalties\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Selling-Drugs-or-Medical-Devices-Without-CDSCO-Approval.png\",\"datePublished\":\"2026-02-12T09:54:23+00:00\",\"dateModified\":\"2026-04-03T11:40:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/#\\\/schema\\\/person\\\/8fffceba7148ae1120f0bd4bf73b0c62\"},\"description\":\"Selling medical devices without CDSCO approval can lead to heavy fines and legal action in India. Check penalties by product category.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/selling-without-cdsco-approval-penalties\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/selling-without-cdsco-approval-penalties\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/selling-without-cdsco-approval-penalties\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Selling-Drugs-or-Medical-Devices-Without-CDSCO-Approval.png\",\"contentUrl\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/Selling-Drugs-or-Medical-Devices-Without-CDSCO-Approval.png\",\"width\":1280,\"height\":288,\"caption\":\"Selling without CDSCO approval\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/selling-without-cdsco-approval-penalties\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CDSCO\",\"item\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/category\\\/cdsco\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Selling Drugs or Medical Devices Without CDSCO Approval: Fines, Legal Risks &amp; Penalties\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/\",\"name\":\"LegalRaasta Knowledge portal\",\"description\":\"Information on company registration, FSSAI, IEC, MSME, trademark, ISO and registrations\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/#\\\/schema\\\/person\\\/8fffceba7148ae1120f0bd4bf73b0c62\",\"name\":\"Author: LegalRaasta\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/author-legalraasta_avatar_1-96x96.png\",\"url\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/author-legalraasta_avatar_1-96x96.png\",\"contentUrl\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/author-legalraasta_avatar_1-96x96.png\",\"caption\":\"Author: LegalRaasta\"},\"description\":\"LegalRaasta is one of India\u2019s leading platforms for Company Registration (Private Limited, LLP, OPC) and GST compliance. Since 2015, our team of experienced CAs and legal experts has assisted over 100,000 businesses with services like Trademark, FSSAI, BIS, and Startup India registration. We simplify complex government processes to help startups and entrepreneurs grow faster. Trusted across India, LegalRaasta makes legal and financial compliance simple, quick, and affordable.\",\"url\":\"https:\\\/\\\/www.legalraasta.com\\\/blog\\\/author\\\/adarshseoexecutive\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Selling Without CDSCO Approval in India? Fines & Legal Risks","description":"Selling medical devices without CDSCO approval can lead to heavy fines and legal action in India. Check penalties by product category.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/","og_locale":"en_US","og_type":"article","og_title":"Selling Without CDSCO Approval in India? Fines & Legal Risks","og_description":"Selling medical devices without CDSCO approval can lead to heavy fines and legal action in India. Check penalties by product category.","og_url":"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/","og_site_name":"LegalRaasta Knowledge portal","article_published_time":"2026-02-12T09:54:23+00:00","article_modified_time":"2026-04-03T11:40:59+00:00","og_image":[{"width":1280,"height":288,"url":"https:\/\/www.legalraasta.com\/blog\/wp-content\/uploads\/2026\/02\/Selling-Drugs-or-Medical-Devices-Without-CDSCO-Approval.png","type":"image\/png"}],"author":"Author: LegalRaasta","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Author: LegalRaasta","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#article","isPartOf":{"@id":"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/"},"author":{"name":"Author: LegalRaasta","@id":"https:\/\/www.legalraasta.com\/blog\/#\/schema\/person\/8fffceba7148ae1120f0bd4bf73b0c62"},"headline":"Selling Drugs or Medical Devices Without CDSCO Approval: Fines, Legal Risks &amp; Penalties","datePublished":"2026-02-12T09:54:23+00:00","dateModified":"2026-04-03T11:40:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/"},"wordCount":1680,"image":{"@id":"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#primaryimage"},"thumbnailUrl":"https:\/\/www.legalraasta.com\/blog\/wp-content\/uploads\/2026\/02\/Selling-Drugs-or-Medical-Devices-Without-CDSCO-Approval.png","articleSection":["CDSCO","Drug License","Medical Device"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/","url":"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/","name":"Selling Without CDSCO Approval in India? Fines & Legal Risks","isPartOf":{"@id":"https:\/\/www.legalraasta.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#primaryimage"},"image":{"@id":"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#primaryimage"},"thumbnailUrl":"https:\/\/www.legalraasta.com\/blog\/wp-content\/uploads\/2026\/02\/Selling-Drugs-or-Medical-Devices-Without-CDSCO-Approval.png","datePublished":"2026-02-12T09:54:23+00:00","dateModified":"2026-04-03T11:40:59+00:00","author":{"@id":"https:\/\/www.legalraasta.com\/blog\/#\/schema\/person\/8fffceba7148ae1120f0bd4bf73b0c62"},"description":"Selling medical devices without CDSCO approval can lead to heavy fines and legal action in India. Check penalties by product category.","breadcrumb":{"@id":"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#primaryimage","url":"https:\/\/www.legalraasta.com\/blog\/wp-content\/uploads\/2026\/02\/Selling-Drugs-or-Medical-Devices-Without-CDSCO-Approval.png","contentUrl":"https:\/\/www.legalraasta.com\/blog\/wp-content\/uploads\/2026\/02\/Selling-Drugs-or-Medical-Devices-Without-CDSCO-Approval.png","width":1280,"height":288,"caption":"Selling without CDSCO approval"},{"@type":"BreadcrumbList","@id":"https:\/\/www.legalraasta.com\/blog\/selling-without-cdsco-approval-penalties\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.legalraasta.com\/blog\/"},{"@type":"ListItem","position":2,"name":"CDSCO","item":"https:\/\/www.legalraasta.com\/blog\/category\/cdsco\/"},{"@type":"ListItem","position":3,"name":"Selling Drugs or Medical Devices Without CDSCO Approval: Fines, Legal Risks &amp; Penalties"}]},{"@type":"WebSite","@id":"https:\/\/www.legalraasta.com\/blog\/#website","url":"https:\/\/www.legalraasta.com\/blog\/","name":"LegalRaasta Knowledge portal","description":"Information on company registration, FSSAI, IEC, MSME, trademark, ISO and registrations","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.legalraasta.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.legalraasta.com\/blog\/#\/schema\/person\/8fffceba7148ae1120f0bd4bf73b0c62","name":"Author: LegalRaasta","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.legalraasta.com\/blog\/wp-content\/uploads\/2026\/03\/author-legalraasta_avatar_1-96x96.png","url":"https:\/\/www.legalraasta.com\/blog\/wp-content\/uploads\/2026\/03\/author-legalraasta_avatar_1-96x96.png","contentUrl":"https:\/\/www.legalraasta.com\/blog\/wp-content\/uploads\/2026\/03\/author-legalraasta_avatar_1-96x96.png","caption":"Author: LegalRaasta"},"description":"LegalRaasta is one of India\u2019s leading platforms for Company Registration (Private Limited, LLP, OPC) and GST compliance. Since 2015, our team of experienced CAs and legal experts has assisted over 100,000 businesses with services like Trademark, FSSAI, BIS, and Startup India registration. We simplify complex government processes to help startups and entrepreneurs grow faster. Trusted across India, LegalRaasta makes legal and financial compliance simple, quick, and affordable.","url":"https:\/\/www.legalraasta.com\/blog\/author\/adarshseoexecutive\/"}]}},"_links":{"self":[{"href":"https:\/\/www.legalraasta.com\/blog\/wp-json\/wp\/v2\/posts\/34121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.legalraasta.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.legalraasta.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.legalraasta.com\/blog\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.legalraasta.com\/blog\/wp-json\/wp\/v2\/comments?post=34121"}],"version-history":[{"count":2,"href":"https:\/\/www.legalraasta.com\/blog\/wp-json\/wp\/v2\/posts\/34121\/revisions"}],"predecessor-version":[{"id":34124,"href":"https:\/\/www.legalraasta.com\/blog\/wp-json\/wp\/v2\/posts\/34121\/revisions\/34124"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.legalraasta.com\/blog\/wp-json\/wp\/v2\/media\/34122"}],"wp:attachment":[{"href":"https:\/\/www.legalraasta.com\/blog\/wp-json\/wp\/v2\/media?parent=34121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.legalraasta.com\/blog\/wp-json\/wp\/v2\/categories?post=34121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.legalraasta.com\/blog\/wp-json\/wp\/v2\/tags?post=34121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}